eHealth

Healthtech / insurance marketplaceUSA
New to Unitard
πŸ“‰ Public < $1B
PeakΒ $3 BillionRecorded estimate
~-98%
from peak
  1. πŸ¦„
    Became a unicorn
    2019
  2. πŸ“ˆ
    Peak valuation
    $3 Billion ’20
  3. πŸ’”
    Became a Unitard
    2021
  4. πŸ’Έ
    Last valuation estimate
    ~$60M
Current status
Public (Nasdaq: EHTH)

The rise & fall

9 moments Β· 1997–2026

The key moments, with employee sentiment along the way.

1997
Founded as eHealthInsurance
One of the first places Americans could buy health coverage online.
Wikipedia
2019
Crosses $1B on the Medicare pivot
A hard pivot into Medicare Advantage and Supplement plans, with booming Medicare-marketing economics behind it.
Macrotrends
Feb 2020
The peak: $152 a share, ~$3B$3B
The stock hits an all-time high of $152.19 as the Medicare machine hums.
Macrotrends
2020
A short-seller takes aim
Muddy Waters goes public with a short case that the Medicare unit's persistency assumptions are far too rosy.
Reuters
2021
The Medicare math stops working
Commission and policy-persistency assumptions prove far too optimistic; restated metrics, retention problems and regulatory scrutiny gut earnings.
stockanalysis
2021
Slips out of the club
Two years a unicorn; the slide takes it back under $1B.
Macrotrends
From the inside Β· Glassdoor reviews, 2021–23
Glassdoor reviews from the slide described a seasonal whiplash: big summer hiring ramps ahead of Medicare's annual enrollment window, then deep spring layoffs β€” with 2022 rounds reviewers said ran to hundreds of jobs β€” plus frequent leadership turnover, repeatedly reworked commission plans, and heavier workloads on fewer staff.
2026
Worth ~$50M β€” about 2% of the peak
The pioneering marketplace shrinks to a micro-cap as the Medicare-marketing model unravels.
stockanalysis

πŸ’¬ entries paraphrase anonymous, unverified reviews posted publicly on Glassdoor β†—; dated facts carry their source.

How it happened

eHealth, a pioneering online health-insurance marketplace, pivoted hard into selling Medicare Advantage and Supplement plans, and booming Medicare-marketing economics drove its stock to an all-time high in early 2020, valuing it near $3B.

But commission and policy-persistency assumptions proved far too optimistic; restated metrics, retention problems and regulatory scrutiny gutted earnings, and the stock fell roughly 98% to around $50M.

Source: Macrotrends / companiesmarketcap / stockanalysis (ATH $152.19 Feb 2020, peak market cap ~$3B; ~$50M market cap by June 2026; Medicare-marketing model unraveled)

Who ran it

  • Derrick Duke
    CEO (since Sept 2025; succeeded Fran Soistman)
    Still there β€” Chief Executive OfficerLinkedIn β†—

Current roles as self-reported on LinkedIn, retrieved 2026-08-19. See our methodology.

More from the club

Same sector Β· Healthtech / insurance marketplace
Same fate Β· market collapse
πŸ¦„